Abstract

The purpose of this paper is to review briefly recent findings on the efficacy of psychopharmacological interventions in autism spectrum disorder, point out gaps in our current knowledge of the effects of specific drug classes, and suggest both general and specific research directions for the future. For a more comprehensive review of drug studies in autism, readers are directed toward McDougle, Price, and Volkmar (1994).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call